Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13
Phase 22

Trial Status

Completed1
Recruiting2
Terminated1
Other1

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT05698524Phase 1Recruiting
A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
Anaplastic AstrocytomaAnaplastic OligodendrogliomaGlioblastoma+2 more
PrincipalinvestigatorStart date: 2023-06-26
NCT03728673Phase 2Recruiting
A Study Utilizing Escitalopram in Glioma Patients
GliomaGlioma of Brain
PrincipalinvestigatorStart date: 2019-03-06
NCT01493219Completed
Biomarkers for Prognosis of Glioblastoma (GBM)
Glioblastoma
PrincipalinvestigatorStart date: 2011-09-20
NCT07859059Phase 1/2Not Yet Recruiting
Metronomic Temozolomide With Dexbrompheniramine for Recurrent High-Grade Glioma/Glioblastoma
GlioblastomaGliosarcomaHigh Grade Glioma
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Thomas Kaley, MD

Memorial Sloan Kettering Cancer Center

Related
9 trials

Shared therapeutic areas:

GlioblastomaAnaplastic AstrocytomaAnaplastic Oligodendroglioma+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score19%

Katherine E Warren, M.D.

National Cancer Institute (NCI)

Related
8 trials

Shared therapeutic areas:

Anaplastic AstrocytomaAnaplastic OligodendrogliomaGliosarcoma+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Sabine Mueller, MD, PhD, MAS

University of California, San Francisco

Related
10 trials

Shared therapeutic areas:

GliomaGlioblastomaGlioma of Brain
Similarity Score11%

Maryam Fouladi, MD

Nationwide Children's Hospital

Related
10 trials

Shared therapeutic areas:

High Grade GliomaAnaplastic AstrocytomaGlioblastoma
Similarity Score11%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

GlioblastomaGliosarcoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Anaplastic AstrocytomaHigh Grade Glioma
Similarity Score8%

John W Glod, M.D.

National Cancer Institute (NCI)

Related
8 trials

Shared therapeutic areas:

Anaplastic AstrocytomaHigh Grade Glioma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Kevin A camphausen, M.D.

National Cancer Institute (NCI)

Related
17 trials

Shared therapeutic areas:

GlioblastomaGliosarcoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Annick Desjardins, MD, FRCPC

Duke University

Related
9 trials

Shared therapeutic areas:

GliosarcomaGlioblastoma
Similarity Score8%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

GlioblastomaGlioma
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT05698524Phase 1PrincipalInvestigator

A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma

Anaplastic AstrocytomaAnaplastic OligodendrogliomaGlioblastoma+2 more
Recruiting
NCT03728673Phase 2PrincipalInvestigator

A Study Utilizing Escitalopram in Glioma Patients

GliomaGlioma of Brain
Recruiting
NCT01493219PrincipalInvestigator

Biomarkers for Prognosis of Glioblastoma (GBM)

Glioblastoma
Completed
NCT02833701Phase 1PrincipalInvestigator

Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma

GlioblastomaGlioma
Terminated
NCT07859059Phase 1/2PrincipalInvestigator

Metronomic Temozolomide With Dexbrompheniramine for Recurrent High-Grade Glioma/Glioblastoma

GlioblastomaGliosarcomaHigh Grade Glioma
Not Yet Recruiting

All 5 trials loaded